Are Medical Stocks Lagging Adagene This Year?
ADAG Stock | USD 1.78 0.03 1.66% |
Roughly 54% of Adagene's investor base is interested to short. The analysis of the overall investor sentiment regarding Adagene suggests that many traders are impartial. The current market sentiment, together with Adagene's historical and current headlines, can help investors time the market. In addition, many technical investors use Adagene stock news signals to limit their universe of possible portfolio assets.
Adagene |
Here is how Adagene Inc. Sponsored ADR and ANI Pharmaceuticals have performed compared to their sector so far this year.
Read at zacks.com
![]() |
Adagene Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Adagene can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Adagene Fundamental Analysis
We analyze Adagene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adagene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adagene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Adagene is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Adagene Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adagene stock to make a market-neutral strategy. Peer analysis of Adagene could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics with similar companies.
Peers
Adagene Related Equities
MOLN | Molecular Partners | 1.64 | ||||
ANAB | AnaptysBio | 0.12 | ||||
PMVP | Pmv Pharmaceuticals | 0.69 | ||||
AVTE | Aerovate Therapeutics | 1.15 | ||||
ANEB | Anebulo Pharmaceuticals | 1.91 | ||||
MLYS | Mineralys Therapeutics, | 2.05 | ||||
ANTX | AN2 Therapeutics | 5.98 | ||||
ACRV | Acrivon Therapeutics, | 6.60 | ||||
RZLT | Rezolute | 8.44 | ||||
JANX | Janux Therapeutics | 8.89 |
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |